共 190 条
[1]
Lyman GH(2007)American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 5490-505
[2]
Khorana AA(2011)Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis Cancer 117 1334-49
[3]
Falanga A(2007)Incidence of venous thromboembolism and the impact on survival in breast cancer patients J Clin Oncol 25 70-6
[4]
Clarke-Pearson D(2008)The incidence of venous thromboembolism among patients with primary lung cancer J Thromb Haemost 6 601-8
[5]
Flowers C(2010)Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines Thromb Res 125 S120-7
[6]
Jahanzeb M(2011)Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines Ann Oncol 22 vi85-92
[7]
Lyman GH(2010)2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group Crit Rev Oncol Hematol 73 31-46
[8]
Chew HK(2009)2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group Ann Oncol 20 1459-71
[9]
Wun T(2008)Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity Thromb Res 122 485-90
[10]
Harvey DJ(2010)Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide Ann Hematol 89 201-6